Capitalization 59.07B 8.35B 7.18B 6.73B 6.27B 11.58B 752B 12.6B 78.69B 30.39B 355B 31.36B 30.69B 1,298B P/E ratio 2025 *
-258x
P/E ratio 2026 * -223x
Enterprise value 59.07B 8.35B 7.18B 6.73B 6.27B 11.58B 752B 12.6B 78.69B 30.39B 355B 31.36B 30.69B 1,298B EV / Sales 2025 *
28.7x
EV / Sales 2026 * 23.2x
Free-Float
18.14%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.37%
1 week-2.77%
Current month-2.77%
1 month-15.31%
3 months-18.49%
6 months-40.42%
Current year-33.74%
More quotes
1 week 45.69
Extreme 45.69
49.68
1 month 45.69
Extreme 45.69
56.04
Current year 45.69
Extreme 45.69
80
1 year 45.69
Extreme 45.69
80
3 years 40.14
Extreme 40.14
106
5 years 40.14
Extreme 40.14
147.67
10 years 4.43
Extreme 4.4335
147.67
More quotes
Manager TitleAgeSince
Chief Executive Officer 52 14/01/2024
Chief Administrative Officer 43 31/12/2006
Investor Relations Contact - -
Director TitleAgeSince
Chairman 62 12/01/2021
Chairman 40 12/04/2018
Director/Board Member 47 04/05/2022
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.37%-2.77%-38.80%-56.34% 8.35B
-0.61%-7.92%-6.45%-4.91% 73.7B
-0.81%-1.18%-34.65%-38.63% 58.94B
+3.17%+2.91%+33.60%+245.77% 54.7B
-2.32%+64.10%+64.10%+64.10% 51.57B
-0.37%-0.43%+13.84%-38.07% 26.6B
-1.66%-2.23%+144.36%+231.53% 20.25B
+2.05%-1.86%+36.84%+21.93% 20.13B
-12.04%-14.35%+46.78%+1,041.25% 16.58B
-1.50%+2.26%+176.22%+703.05% 14.19B
Average -1.37%-2.95%+43.58%+216.97% 34.5B
Weighted average by Cap. -0.75%-2.56%+27.86%+130.41%
See all sector performances

Financials

2025 *2026 *
Net sales 2.06B 291M 250M 235M 219M 404M 26.21B 439M 2.74B 1.06B 12.38B 1.09B 1.07B 45.26B 2.55B 361M 310M 290M 271M 500M 32.47B 544M 3.4B 1.31B 15.33B 1.35B 1.33B 56.07B
Net income -229M -32.43M -27.88M -26.12M -24.34M -44.96M -2.92B -48.91M -305M -118M -1.38B -122M -119M -5.04B -266M -37.61M -32.33M -30.29M -28.23M -52.14M -3.39B -56.72M -354M -137M -1.6B -141M -138M -5.85B
Net Debt - -
More financial data * Estimated data
Logo Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Beijing Wantai Biological Pharmacy Enterprise Co Ltd is a China-based company mainly engaged in the production and sale of vaccine products. The Company operates two segments. Diagnostic segment produces and sells in vitro diagnostic reagents and instruments suitable for in vitro diagnostic reagent testing. Vaccine segment produces and sells vaccines. The in vitro diagnostic reagents mainly include enzyme-linked immunosorbent assay reagents, colloidal gold diagnostic reagents, biochemical diagnostic reagents, chemiluminescent diagnostic reagents, and others. The in vitro diagnostic instruments include fully automatic chemiluminescent immunoassay analyzers, dry fluorescent immunoassay analyzers, fully automatic nucleic acid purification, and others. The vaccines mainly include hepatitis E vaccine, bivalent human papillomavirus (HPV) vaccine and nasal spray COVID-19 vaccine.
Employees
3,790
More about the company
Date Price Change Volume
05/12/25 46.69 ¥ +0.37% 3,001,993
04/12/25 46.52 ¥ -0.39% 2,655,228
03/12/25 46.70 ¥ -1.95% 4,744,520
02/12/25 47.63 ¥ -2.90% 4,029,798
01/12/25 49.05 ¥ +2.14% 5,784,488

End-of-day quote Shanghai S.E., December 04, 2025

More quotes
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
1
Last Close Price
46.69CNY
Average target price
50.00CNY
Spread / Average Target
+7.09%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 603392 Stock